about
Serious drug-induced liver disease secondary to ezetimibe.Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries.Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.Impact of the ENHANCE trial on the use of ezetimibe in the United States and CanadaThe potential economic impact of restricted access to angiotensin-receptor blockersUse of fibrates in the United States and CanadaFDA Policy and Cardiovascular Medicine.Simvastatin and atorvastatin reduce the mechanical properties of tendon constructs in vitro and introduce catabolic changes in the gene expression pattern.What explains the diffusion of treatments for mental illness?Is American health care uniquely inefficient?Selegiline shortage: Causes and costs of a generic drug shortage.Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.The impact of ezetimibe on endothelial function and other markers of cardiovascular risk.Ezetimibe: Use, costs, and adverse events in Australia.Ezetimibe plus simvastatin for the treatment of hypercholesterolemia.Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.Ezetimibe: Clinical and Scientific Meaning of the IMPROVE-IT Study.The Core Value of Cost-Effectiveness Analyses.Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.Promoting transparency in pharmaceutical industry-sponsored research.
P2860
Q33365589-9226DE6B-8E3B-4FFB-B415-9F0E0CDA2A6EQ33789084-BB91122E-7E66-473B-8E5E-F4DC90DAB70BQ33828039-A7D1D7A2-4902-4976-9627-FCD4FFC67E20Q34400871-4FA8FC39-72F6-4968-9CA6-FCA0F1EAC700Q34432003-668B4985-8201-4E7F-8C95-DBB33DC50FCAQ34590001-7A763C3C-1640-4DBC-B3BA-851C90297435Q35903762-378A7865-03AA-42F9-B534-C661F483D186Q36100416-6E0B986E-66ED-4C39-B2FD-631DE95A8385Q36298618-6218A6F4-0B3C-4821-93D0-3BE2E8D5ED05Q37108584-57F7C844-4072-43CB-916C-E308C7C64A75Q37136983-8757E27E-1791-4FA0-AAF5-FEF875627875Q37274603-A583BFD5-9851-4C19-95B5-C238FBAB5BA8Q37402089-8FBF3613-2564-4DD3-BAE9-348FB65DC0FEQ37460853-9EFFA0A8-64BC-40A4-BF22-0B50B5110F63Q37634194-3B0E967A-D6AE-4042-9686-4AC6D2BC2779Q38404338-7532374F-2915-4B40-A9B1-93DAA9E937CFQ38446859-33C024B5-24B8-42B8-B75C-848FF976E55DQ38546242-533F692B-6E0D-4C06-9DB5-D0AEAF736FF8Q39621525-B80D3FB7-E3BE-480D-907F-20669BF14383Q42342395-17A4604E-6A0C-4CEF-9691-4709296914CCQ43430988-24BE04F2-05C2-4D7D-86D3-87D4A8AFFC89Q46076333-F6207039-7E9E-4E56-916A-D7BEC8BE1E72Q53091529-C49F7E15-4709-42E9-B92C-D15623B8A875
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Use of ezetimibe in the United States and Canada.
@en
Use of ezetimibe in the United States and Canada.
@nl
type
label
Use of ezetimibe in the United States and Canada.
@en
Use of ezetimibe in the United States and Canada.
@nl
prefLabel
Use of ezetimibe in the United States and Canada.
@en
Use of ezetimibe in the United States and Canada.
@nl
P50
P356
P1476
Use of ezetimibe in the United States and Canada.
@en
P2093
Cynthia A Jackevicius
P304
P356
10.1056/NEJMSA0801461
P407
P577
2008-03-30T00:00:00Z